1. Home
  2. DNUT vs LXEO Comparison

DNUT vs LXEO Comparison

Compare DNUT & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krispy Kreme Inc.

DNUT

Krispy Kreme Inc.

HOLD

Current Price

$3.65

Market Cap

660.4M

ML Signal

HOLD

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

HOLD

Current Price

$7.37

Market Cap

731.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNUT
LXEO
Founded
1937
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
660.4M
731.3M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
DNUT
LXEO
Price
$3.65
$7.37
Analyst Decision
Buy
Strong Buy
Analyst Count
6
10
Target Price
$6.22
$18.60
AVG Volume (30 Days)
2.4M
1.8M
Earning Date
02-24-2026
11-05-2025
Dividend Yield
1.93%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,534,272,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.19
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.50
$1.45
52 Week High
$9.56
$10.99

Technical Indicators

Market Signals
Indicator
DNUT
LXEO
Relative Strength Index (RSI) 34.87 35.65
Support Level $4.12 $6.90
Resistance Level $4.49 $10.75
Average True Range (ATR) 0.22 0.85
MACD -0.07 -0.32
Stochastic Oscillator 3.30 12.73

Price Performance

Historical Comparison
DNUT
LXEO

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.

Share on Social Networks: